137 related articles for article (PubMed ID: 14506247)
1. PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation.
Chou FL; Hill JM; Hsieh JC; Pouyssegur J; Brunet A; Glading A; Uberall F; Ramos JW; Werner MH; Ginsberg MH
J Biol Chem; 2003 Dec; 278(52):52587-97. PubMed ID: 14506247
[TBL] [Abstract][Full Text] [Related]
2. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
[TBL] [Abstract][Full Text] [Related]
3. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
Glading A; Koziol JA; Krueger J; Ginsberg MH
Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
[TBL] [Abstract][Full Text] [Related]
4. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.
Whitehurst AW; Robinson FL; Moore MS; Cobb MH
J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138
[TBL] [Abstract][Full Text] [Related]
5. The death effector domain of PEA-15 is involved in its regulation of integrin activation.
Ramos JW; Kojima TK; Hughes PE; Fenczik CA; Ginsberg MH
J Biol Chem; 1998 Dec; 273(51):33897-900. PubMed ID: 9852038
[TBL] [Abstract][Full Text] [Related]
6. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.
Formstecher E; Ramos JW; Fauquet M; Calderwood DA; Hsieh JC; Canton B; Nguyen XT; Barnier JV; Camonis J; Ginsberg MH; Chneiweiss H
Dev Cell; 2001 Aug; 1(2):239-50. PubMed ID: 11702783
[TBL] [Abstract][Full Text] [Related]
7. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site.
Callaway K; Abramczyk O; Martin L; Dalby KN
Biochemistry; 2007 Aug; 46(32):9187-98. PubMed ID: 17658892
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation.
Krueger J; Chou FL; Glading A; Schaefer E; Ginsberg MH
Mol Biol Cell; 2005 Aug; 16(8):3552-61. PubMed ID: 15917297
[TBL] [Abstract][Full Text] [Related]
9. Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.
Hughes PE; Oertli B; Hansen M; Chou FL; Willumsen BM; Ginsberg MH
Mol Biol Cell; 2002 Jul; 13(7):2256-65. PubMed ID: 12134066
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase controls neurite outgrowth in N1E-115 neuroblastoma cells.
Ishii T; Satoh E; Nishimura M
J Biol Chem; 2001 Nov; 276(46):42994-3003. PubMed ID: 11560928
[TBL] [Abstract][Full Text] [Related]
11. Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK.
Mace PD; Wallez Y; Egger MF; Dobaczewska MK; Robinson H; Pasquale EB; Riedl SJ
Nat Commun; 2013; 4():1681. PubMed ID: 23575685
[TBL] [Abstract][Full Text] [Related]
12. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
Hong SK; Yoon S; Moelling C; Arthan D; Park JI
J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase activated by epidermal growth factor and cell adhesion interacts with and phosphorylates vinexin.
Mitsushima M; Suwa A; Amachi T; Ueda K; Kioka N
J Biol Chem; 2004 Aug; 279(33):34570-7. PubMed ID: 15184391
[TBL] [Abstract][Full Text] [Related]
14. Integrin and FAK-mediated MAPK activation is required for cyclic strain mitogenic effects in Caco-2 cells.
Li W; Duzgun A; Sumpio BE; Basson MD
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G75-87. PubMed ID: 11123200
[TBL] [Abstract][Full Text] [Related]
15. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.
Ramos JW; Hughes PE; Renshaw MW; Schwartz MA; Formstecher E; Chneiweiss H; Ginsberg MH
Mol Biol Cell; 2000 Sep; 11(9):2863-72. PubMed ID: 10982386
[TBL] [Abstract][Full Text] [Related]
16. Membrane localization of Raf assists engagement of downstream effectors.
Farrar MA; Tian J; Perlmutter RM
J Biol Chem; 2000 Oct; 275(40):31318-24. PubMed ID: 10913130
[TBL] [Abstract][Full Text] [Related]
17. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
[TBL] [Abstract][Full Text] [Related]
18. Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.
Haling JR; Wang F; Ginsberg MH
Mol Biol Cell; 2010 Feb; 21(4):664-73. PubMed ID: 20032303
[TBL] [Abstract][Full Text] [Related]
19. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene.
Liu JC; Baker RE; Sun C; Sundmark VC; Elsholtz HP
J Biol Chem; 2002 Sep; 277(39):35819-25. PubMed ID: 12121979
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation.
Osawa M; Itoh S; Ohta S; Huang Q; Berk BC; Marmarosh NL; Che W; Ding B; Yan C; Abe J
J Biol Chem; 2004 Jul; 279(28):29691-9. PubMed ID: 15078886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
